What The Article Says: An oncologist reflects on how advising patients with cancer about travel during a pandemic requires a nuanced consideration of benefit and risk, especially when considering lost opportunities when prognosis is limited.
Authors: Christopher E. Jensen, M.D., of the University of North Carolina School of Medicine in Chapel Hill, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2021.0125)
Editor's Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0125?guestAccessKey=8bb2301f-87a5-4ef2-a8b9-b4854a0509ca&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031821
JAMA Oncology